看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 19.4x - 21.4x | 20.4x |
| Selected Fwd EBITDA Multiple | 17.4x - 19.2x | 18.3x |
| Fair Value | €155.36 - €173.68 | €164.52 |
| Upside | -9.8% - 0.8% | -4.5% |
| Benchmarks | Ticker | Full Ticker |
| Bio-Techne Corporation | TECH | NasdaqGS:TECH |
| Revvity, Inc. | RVTY | NYSE:RVTY |
| Thermo Fisher Scientific Inc. | TMO | NYSE:TMO |
| Mesa Laboratories, Inc. | MLAB | NasdaqGS:MLAB |
| Azenta, Inc. | AZTA | NasdaqGS:AZTA |
| Danaher Corporation | DAP | DB:DAP |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| TECH | RVTY | TMO | MLAB | AZTA | DAP | ||
| NasdaqGS:TECH | NYSE:RVTY | NYSE:TMO | NasdaqGS:MLAB | NasdaqGS:AZTA | DB:DAP | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 3.2% | 6.6% | 10.9% | 15.0% | 7.5% | 10.9% | |
| 3Y CAGR | -11.8% | -21.4% | -5.8% | 12.2% | -5.9% | -6.4% | |
| Latest Twelve Months | -24.9% | 7.5% | -0.2% | -0.8% | 75.3% | 0.8% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 28.8% | 35.5% | 28.3% | 18.1% | 2.3% | 33.1% | |
| Prior Fiscal Year | 26.8% | 29.6% | 25.4% | 16.3% | 2.0% | 31.6% | |
| Latest Fiscal Year | 19.1% | 30.4% | 25.3% | 17.5% | 3.3% | 31.4% | |
| Latest Twelve Months | 19.1% | 30.0% | 25.0% | 16.2% | 5.1% | 31.3% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 6.89x | 4.55x | 4.84x | 2.09x | 1.27x | 6.61x | |
| EV / LTM EBITDA | 36.1x | 15.2x | 19.3x | 12.9x | 24.9x | 21.1x | |
| EV / LTM EBIT | 68.3x | 29.8x | 26.3x | 35.5x | -15.3x | 30.9x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 12.9x | 19.3x | 36.1x | ||||
| Historical EV / LTM EBITDA | 19.3x | 25.6x | 31.8x | ||||
| Selected EV / LTM EBITDA | 19.4x | 20.4x | 21.4x | ||||
| (x) LTM EBITDA | 7,521 | 7,521 | 7,521 | ||||
| (=) Implied Enterprise Value | 145,577 | 153,239 | 160,901 | ||||
| (-) Non-shareholder Claims * | (15,606) | (15,606) | (15,606) | ||||
| (=) Equity Value | 129,971 | 137,633 | 145,295 | ||||
| (/) Shares Outstanding | 716.1 | 716.1 | 716.1 | ||||
| Implied Value Range | 181.51 | 192.21 | 202.91 | ||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | |||
| Implied Value Range (Trading Cur) | 155.37 | 164.53 | 173.69 | 172.22 | |||
| Upside / (Downside) | -9.8% | -4.5% | 0.9% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | TECH | RVTY | TMO | MLAB | AZTA | DAP | |
| Enterprise Value | 8,144 | 12,496 | 203,360 | 495 | 630 | 159,670 | |
| (+) Cash & Short Term Investments | 162 | 992 | 6,390 | 23 | 319 | 2,957 | |
| (+) Investments & Other | 0 | 0 | 174 | 0 | 387 | 0 | |
| (-) Debt | (444) | (3,375) | (35,229) | (185) | (53) | (18,555) | |
| (-) Other Liabilities | 0 | 0 | (91) | 0 | 0 | (8) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 7,862 | 10,113 | 174,604 | 333 | 1,283 | 144,064 | |
| (/) Shares Outstanding | 156.8 | 117.9 | 377.6 | 5.5 | 45.8 | 716.1 | |
| Implied Stock Price | 50.15 | 85.80 | 462.39 | 60.49 | 27.98 | 201.19 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 50.15 | 85.80 | 462.39 | 60.49 | 27.98 | 172.22 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |